Clinical trial
Evaluation of PACE4 Isoforms as Biomarkers in Thyroid Cancer
NCT03160482 is registered in ClinicalTrials.gov with Robert Day as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of PACE4 Isoforms as Biomarkers in Thyroid Cancer
- Lead sponsor
- Robert Day
- Phase
- Observational
- Overall status
- Completed
- Start date
- May 15, 2017
- Completion date
- January 15, 2018
- Enrollment
- 39 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.